SANGAMO THERAPEUTICS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $24.94 million as of 2023-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2025-03-17
- 2023-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $24.94M.
- 2023-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $34.42M.
- 2023-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $39.04M.
- 2023-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $35.61M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five |
|---|---|
| 2023-12-31 | $24.94M 10-K · filed 2025-03-17 |
| 2023-09-30 | $34.42M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $39.04M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $35.61M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $29.84M 10-K · filed 2024-03-13 |
| 2021-12-31 | $88.17M 10-K · filed 2023-02-23 |
| 2020-12-31 | $50.53M 10-K · filed 2022-02-24 |
| 2019-12-31 | $21.83M 10-K · filed 2021-02-24 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-28 |